Proteinuria reduction: mandatory consideration or option when selecting an antihypertensive agent? (Q36255432)
scientific article
Language:
(P31) (Q13442814)
(P304) 374-378
(P407) (Q1860)
(P433) 5
(P478) 7
(P577) Saturday, October 1, 2005
(P1433) (Q15746362)
(P1476) "Proteinuria reduction: mandatory consideration or option when selecting an antihypertensive agent?" (language: en)
(P2093) Robert D Toto
(P2860) (Q40205923)
(Q43576144)
(Q44579295)
(Q45113233)
(Q34753900)
(Q44242786)
(Q44358769)
(Q34293849)
(Q44280775)
(Q43734845)
(Q35945733)
(Q44295713)
(Q38557081)
(Q34906496)
(Q43626458)
(Q35946242)
(Q34552302)
(Q40509707)
(Q57703949)
(Q47281655)
(Q72967212)
(Q35918595)
(Q35776372)
(Q79330505)
(Q28188162)
(Q44218873)
(Q29615215)
(Q43442381)
(Q45012594)
(Q80010742)
(Q28204197)
(Q70513402)
(P13046) (Q7318358)
other details
description scientific article

External Links